Mark Tullis
Mark is Co-founder/Editor of TechBuzz News. From Ogden, UT, Mark attended WSU, BYU, and Tufts. He has been involved in tech, media, publishing since the 80s.
Today, on the heels of appointing former Shopify executive Loren Padelford as COO, Podium announced $201M in Series D funding led by YC Continuity (Y Combinator's venture capital fund, founded in 2015). Other participating investors include: Durable Capital Partners of Chevy Chase, Maryland; Arpex Capital of São Paulo,
by Mark TullisOn November 11, 2021, Videra Health announced it has raised $3 million in seed funding to address the dearth of patient-provider engagement between appointments. The round was led by Peterson Ventures, with participation from Rose Park Advisors and OATV. Videra Health hosts thousands of patient engagements every month for behavioral
by Mark TullisHivewire, a no-code client onboarding platform startup, announced today it has raised $7.25 million in seed funding. The round was led by Pelion Venture Partners. Participating investors include Peterson Ventures, who led a pre-seed round in fall of 2019 which included Elevation Capital and Village Global. New investors in
by Mark TullisFollowing its recent $20 million raise, as covered by TechBuzz, on November 8, 2021 Udo announced its first acquisition: Smile Virtual, a virtual care company connecting dentists with patients wanting to improve their smiles. Phoenix-based Smile Virtual facilitates virtual communication between dentists and patients with the goal of improving smiles.
by Mark TullisA new initiative, the Intermountain Intelligence, Industry, and Security Consortium (I3SC) announced its launch on November 2, 2021. The I3SC is a partnership with Utah State University’s Center for Anticipatory Intelligence (CAI), Utah Valley University’s Center for National Security Studies (CNSS), and industry partners, including Adobe, AgilePQ, FireEye,
by Mark TullisClene Announces Phase II Clinical Trial Results On November 2, 2021, Clene Nanomedicine announced final results of all 45 patients participating in one of its randomized Phase II clinical trials called RESCUE-ALS. The trial has been evaluating Clene's main product, CNM-Au8, a catalytically active gold nanotherapeutic for people
by Mark TullisIn late 2017, Glen Mella met with Dr. Milton Lee, a recently retired BYU professor with four decades of experience teaching and applying chemistry both in the classroom and in the real world. While at BYU, Lee founded successfully spun out three tech companies from his lab, all with a
by Mark TullisQualtrics co-founder Scott Smith and wife donate $25 Million to UVU On October 27, 2021, Qualtrics co-founder Scott M. Smith and his wife Karen Smith announced plans to bestow a $25 million gift to help fund Utah Valley University’s (UVU) planned engineering building. The new building will be named
by Mark Tullis